Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA.
about
Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapyTherapies for the bone in mucopolysaccharidosesMorquio A syndrome: diagnosis and current and future therapiesHematopoietic stem cell transplantation for Morquio A syndrome.Impact of Enzyme Replacement Therapy and Hematopoietic Stem Cell Therapy on Growth in Patients with Hunter Syndrome.Establishment of glycosaminoglycan assays for mucopolysaccharidosesImpact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB.Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.Activity of daily living for Morquio A syndrome.Mucopolysaccharidosis IVA and glycosaminoglycans.Current therapies for Morquio A syndrome and their clinical outcomes.Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.Nanotechnology applied to treatment of mucopolysaccharidoses.Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.Cell-Based Therapies: The Nonresponder
P2860
Q26771159-56706FB1-EA6D-4755-BBAF-5989340BEFCDQ26852308-EB58F9A0-FABE-43F7-88E6-EA9897958A69Q27014063-DD113705-9ECE-4E5B-8136-9FCE8357FF7EQ30809579-03B95520-73BD-4A4D-8BC0-8457227358E3Q33923815-70DB7FA0-F8DB-4A61-8F19-CDC31E91D10BQ34318230-567F06C0-56C4-4890-B845-71359B6B5E41Q35319254-4F7F181D-D70F-4ADF-97EB-F775258B3CC1Q35752500-DA07C8F7-C9A3-4495-94A3-21854D2B116DQ36677856-A5853ADD-7517-4884-8721-25D9E16D640CQ37243265-FF8C77C1-3D08-4E9A-8C83-F09147136A8FQ37626886-EA40FD89-D9F3-415A-B3C6-876DBAACBB44Q37646091-E6DC23D1-83B7-4F5E-AFFE-A3AE22BCCEB9Q38695475-A2F8D163-7AD4-436E-8B2C-F23DFB36589AQ38850942-BFFF8D19-1C2B-4AB7-AFF9-4B8D2A16EFBEQ54987125-7FD4AA14-9BB1-4556-BA6B-553ECF95A367Q58696783-DE49D3BF-C2B9-4381-9986-086910EAF720
P2860
Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@ast
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@en
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@nl
type
label
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@ast
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@en
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@nl
prefLabel
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@ast
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@en
Long-term therapeutic efficacy ...... ith mucopolysaccharidosis IVA.
@nl
P2093
P2860
P1476
Long-term therapeutic efficacy ...... with mucopolysaccharidosis IVA
@en
P2093
Nobuyuki Hyakuna
Tadao Orii
Takeshi Higa
Yasutsugu Chinen
Yasuyuki Suzuki
P2860
P356
10.1016/J.YMGMR.2013.11.002
P577
2014-01-01T00:00:00Z